최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기藥劑學會誌 = Journal of Korean pharmaceutical sciences, v.33 no.2, 2003년, pp.85 - 89
홍석천 (한국유나이티드제약(주) 중앙연구소) , 유창훈 (한국유나이티드제약(주) 중앙연구소) , 조동현 (한국유나이티드제약(주) 중앙연구소) , 신현종 (한국유나이티드제약(주) 중앙연구소) , 길영식 (한국유나이티드제약(주) 중앙연구소)
Piroxicam-arginine complex was prepared to improve the solubility and dissolution rate of poorly water-soluble piroxicam. Its formation was identified by infrared spectrophotometry, differential thermal analysis and dissolution rate. Piroxicam complex dispersible tablets, commercial
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Gerald K.M., AHFS Drug Information, ASHP, Inc.,Wisconsin, U.S.A., pp. 2016-2020 (2002)
Karim A, Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of proteinbinding differences on steady-state pharmaco-kinetics. J. Clin. Pharmacol., 37, 267-278 (1997).
Sean CS, Martindale; The Complete Drug Reference, Pharmaceutical press, London, UK., pp. 79-80 (2002)
I.E. Koh and S.C. Shin and I.J. on, Enhancement of dissolution properties of poorly soluble drugs (IV): Micronization of furosemide by recrystallization method, J. Kor. Pharm. Sci., 18, 55-59 (1998).
C.K. Kim and H.J. Shin, Soluble complex formation of rifampicin with arginine, Yakhak Hoeji; 27, 11-19 (1983).
J. H. Kim and H.Y Choi, Complexation of piroxicam and tenoxicam with hydroxypropyl- $\beta$ -cyclodexrrin, J. Kor. Pharm. Sci., 30, 33-37 (2000).
I.J. Oh, J.G. Park, Y.B. Lee and S.C. Shin, Inclusion complex of analgesic and anti-inflammatory agents with cyclodextrins (1): Enhancement of dissolution of ibuprofen by 2-hydroxypropyl- $\beta$ -cyclodextrin, J Kar. Pharm. Sci., 23, 11-18 (1993).
S.H. Park, C.H. Lee, Y.W. Choi, G.B. Park and J.K. Kim, Bioavailability studies on suspension of inclusion complexes of piroxicam with cyclodextrin, Kar. J. Clin. Pharm., 1, 914 (1991)
S.S. Jeon, H.R. Cha, Y.J. Park, B.C. Lee and N.D. Kim, Comparison of absorption rate between piroxicam- $\beta$ -pcyclodextrin and piroxicam in Korean healthy subjects after a single dose administration, Kor. J. Clin. Pharm., 8, 95-100 (1998)
E.S. Park, B.J. Yun and S.C. Chi, Pharmacokinetic and pharmacological evaluation of topical microemulsion preparation containing piroxicam, J. Appl. Pharmacol., 7, 54-58 (1999)
Y.B. Jun, S.I. Kim and Y.I. Kim, Effect of surfactants on dissolution rate of mefenamic acid capsules, J. Kor. Pharm. Sci., 20, 121-127 (1990).
T.S. Lee and B.J. Lee, Enhancement of dissolution rate of poorly water-soluble ibuprofen using solid dispersions and inclusion complex, J. Kor. Pharm. Sci., 25, 31-36 (1995)
J.H. Moon and I.K. Chun, Enhanced dissolution and permeation of biphenyl dimethyl dicarboxylate using solid dispersions, J. Kar. Pharm. Sci., 29, 227-234 (1999)
G.S. Khang, J.M. Lee, H.C. Shin, H.B. Lee and J.K. Jeong, Effect of molecular weights and mixture ratios of polyvinylpyrrolidon on the bioavailability of ipriflavone solid dispersion, J. Kor. Pharm. Sci., 30, 235-239 (2000)
Y.J. Lee, Y.G. Kim, M.G. Lee, S.J. Chung, M.H. Lee and C.K. Shim, Analysis of bioequivalence study using longtransformed model, Yakhak Hoeji, 44, 308-314 (2000)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.